首页> 美国卫生研究院文献>Drug Delivery >Gefitinib loaded nanostructured lipid carriers: characterization evaluation and anti-human colon cancer activity in vitro
【2h】

Gefitinib loaded nanostructured lipid carriers: characterization evaluation and anti-human colon cancer activity in vitro

机译:吉非替尼负载的纳米结构脂质载体:体外的表征评估和抗人结肠癌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

NLC containing Gefitinib (NANOGEF) was prepared using stearic acid, sesame oil and surfactants (sodium lauryl sulfate and tween 80). NANOGEFs were evaluated for particle size, polydispersity index (PdI), zeta potential, entrapment efficiency (EE), stability, release studies and cytotoxicity studies (MTT assay). The optimized NANOGEF exhibited particle size of 74.06 ± 9.73 d.nm, PdI of 0.339 ± 0.029 and EE of 99.76 ± 0.015%. The TEM study revealed spherical shape of NANOGEF formulations. The slow and sustained release behavior was exhibited by all NANOGEFs. The effects of surfactants were observed not only on particle size but also on zeta potential, entrapment efficiency, stability and release studies. The MTT assay revealed 4.5 times increase in cytotoxicity for optimized NANOGEF (IC = 4.642 µM) when compared with Gefitinib alone (IC = 20.88 µM in HCT-116 cells). Thus NANOGEF may be considered as a potential drug delivery system for the cure of colon cancer.
机译:使用硬脂酸,芝麻油和表面活性剂(十二烷基硫酸钠和吐温80)制备含有吉非替尼(NANOGEF)的NLC。对NANOGEF进行了粒度,多分散指数(PdI),ζ电势,包封率(EE),稳定性,释放研究和细胞毒性研究(MTT测定)的评估。优化后的NANOGEF的粒径为74.06±9.73 d.nm,PdI为0.339±0.029,EE为99.76±0.015%。 TEM研究显示了NANOGEF配方的球形。所有NANOGEF均表现出缓慢和持续释放的行为。不仅观察到表面活性剂对颗粒大小的影响,而且还观察到对ζ电势,截留效率,稳定性和释放性的研究。 MTT分析显示,与单独使用吉非替尼(在HCT-116细胞中IC = 20.88 µM)相比,优化后的NANOGEF(IC = 4.642 µM)的细胞毒性增加了4.5倍。因此NANOGEF可以被认为是治疗结肠癌的潜在药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号